MeSH term
Frequency | Condition_Probility | Abdomen | 2 | 2.0 |
Adult | 22 | 0.0 |
Case-Control Studies | 7 | 0.0 |
Female | 27 | 0.0 |
Humans | 48 | 0.0 |
Male | 25 | 0.0 |
Middle Aged | 22 | 0.0 |
Mutation | 2 | 0.0 |
Odds Ratio | 3 | 0.0 |
Polymorphism, Genetic | 10 | 0.0 |
Receptors, Adrenergic, beta-2/*genetics | 24 | 96.0 |
Research Support, Non-U.S. Gov't | 34 | 0.0 |
Risk Factors | 6 | 0.0 |
Sex Factors | 3 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Asthma/*genetics | 2 | 3.0 |
Linkage Disequilibrium | 3 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
*Variation (Genetics) | 3 | 0.0 |
Alleles | 8 | 0.0 |
Body Mass Index | 5 | 0.0 |
Body Weight | 2 | 0.0 |
Child | 5 | 0.0 |
Child, Preschool | 3 | 0.0 |
Cohort Studies | 4 | 0.0 |
Cross-Sectional Studies | 3 | 0.0 |
Energy Metabolism | 2 | 1.0 |
Gene Frequency | 9 | 0.0 |
Genotype | 26 | 0.0 |
*Polymorphism, Genetic | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Glucose Tolerance Test | 2 | 0.0 |
Obesity/epidemiology/*genetics | 2 | 18.0 |
Phenotype | 4 | 0.0 |
Blood Pressure/physiology | 3 | 1.0 |
Receptors, Adrenergic, beta/*genetics | 3 | 15.0 |
Animals | 5 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Receptor, Serotonin, 5-HT2A | 2 | 5.0 |
Receptors, Serotonin/*genetics | 2 | 2.0 |
Polymorphism, Restriction Fragment Length | 8 | 0.0 |
Arginine/genetics | 2 | 1.0 |
*Body Mass Index | 2 | 2.0 |
Receptors, Adrenergic, beta-3/*genetics | 2 | 10.0 |
Age Factors | 3 | 0.0 |
Aged | 7 | 0.0 |
Comparative Study | 4 | 0.0 |
Gene Deletion | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 5 | 0.0 |
*Chromosomes, Human, Pair 5 | 6 | 2.0 |
Genetic Markers | 5 | 0.0 |
Genetic Predisposition to Disease | 5 | 0.0 |
Glutamic Acid/genetics | 3 | 7.0 |
Glutamine/genetics | 4 | 8.0 |
Hypertension/epidemiology/*genetics | 2 | 10.0 |
Blood Pressure/genetics | 3 | 8.0 |
Family Health | 2 | 0.0 |
Glycine/genetics | 2 | 2.0 |
Hypertension/ethnology/*genetics | 2 | 16.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Blood Glucose/metabolism | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Insulin/blood | 2 | 0.0 |
Leptin/blood | 2 | 3.0 |
Exercise | 2 | 1.0 |
Oxygen Consumption | 3 | 1.0 |
DNA/genetics | 2 | 0.0 |
Hypertension/*genetics/physiopathology | 2 | 8.0 |
Japan | 3 | 0.0 |
Age of Onset | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Gene Dosage | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Myelodysplastic Syndromes/*genetics | 3 | 4.0 |
Cardiovascular Diseases/genetics | 2 | 7.0 |
Adolescent | 5 | 0.0 |
Homozygote | 2 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
Asthma/genetics | 2 | 15.0 |
Haplotypes/*genetics | 2 | 1.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
*Chromosome Deletion | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
English Abstract | 2 | 0.0 |
Obesity/*genetics/metabolism | 3 | 21.0 |
Base Sequence | 4 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Chromosomes, Human, Pair 5 | 2 | 1.0 |
DNA Primers | 2 | 0.0 |
Receptors, Adrenergic/*genetics | 3 | 50.0 |
Haplotypes | 2 | 0.0 |
Interleukin-4/*genetics | 2 | 4.0 |
Cloning, Molecular | 2 | 0.0 |
Receptors, Adrenergic, beta-2/genetics | 3 | 42.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Analysis of Variance | 2 | 0.0 |
Polymerase Chain Reaction/methods | 3 | 0.0 |
Pharmacogenetics/*methods | 2 | 11.0 |
